Yogesh A. Sonawane

Chemically induced degradation of CDK9 by a proteolysis targeting chimera (PROTAC)

Caroline M. Robb, Jacob I. Contreras, Smit Kour et al. · Chemical Communications · 2017 · 209 citations

Life Sciences, Biochemistry, Molecular Biology +13

Cyclin Dependent Kinase 9 Inhibitors for Cancer Therapy

Yogesh A. Sonawane, Margaret Taylor, John V. Napoleon et al. · Journal of Medicinal Chemistry · 2016 · 153 citations · Full text

Medicine, Cancer Biology, Oncology +14

Synthesis of Diphenylamine-Based Novel Fluorescent Styryl Colorants by Knoevenagel Condensation Using a Conventional Method, Biocatalyst, and Deep Eutectic Solvent

Yogesh A. Sonawane, Sunanda B. Phadtare, Bhushan Nanasaheb Borse et al. · Organic Letters · 2010 · 134 citations

Natural Sciences, Chemical Engineering, Chemistry +16

Characterization of CDK(5) inhibitor, 20-223 (aka CP668863) for colorectal cancer therapy

Caroline M. Robb, Smit Kour, Jacob I. Contreras et al. · Oncotarget · 2017 · 53 citations · Full text

Medicine, Oncology, Pharmacology +17

In search of selective 11β-HSD type 1 inhibitors without nephrotoxicity: An approach to resolve the metabolic syndrome by virtual based screening

Harun Patel, Kiran Dhangar, Yogesh A. Sonawane et al. · Arabian Journal of Chemistry · 2015 · 31 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +14